News

When combined with corticosteroids, the oral therapy appeared to be as effective as IVCY with a more favorable safety profile.

A consensus was reached on nearly all proposals in the eDelphi study, which members said could be used to establish a clear dosing regimen for methotrexate.

The agency cited an increased risk of thromboembolic events driven by vascular access thrombosis in dialysis patients and increased risk of drug-induced liver injuries.

Furthermore, psoriatic treatment did not appear to significantly reduce COVID-19 vaccine efficacy.

Males between 50-64 who have been vaccinated without erythema were at the highest risk of GBS.

Female academic ophthalmologists were paid a mean of $50,300 less than male peers.

Influenza vaccination rates remain low within patients with rheumatoid arthritis. Investigators urge rheumatologists to encourage vaccination acceptance as a part of routine care.

Previously, few rapid diagnostic tests have been studied in home environments, and there are currently no tests approved for at-home influenza detection by the Food and Drug Administration (FDA)

Patients with psoriatic arthritis and ankylosing spondylitis experienced rapid pain reduction with upadacitinib, regardless of treatment history.

Chronic stressors may play an important role in the development of chronic pain, leading to excess cortisol production and disruption to the body's sympathetic and parasympathetic systems.

The inaugural episode of Diabetes Dialogue features an introduction to hosts Diana Isaacs, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP, and Natalie Bellini, DNP, FNP-BC, and a discussion around recent regulatory news surrounding CGM devices in the US and Europe.

Headed to ACC.22 this weekend or following along virtually? Hear from Don't Miss a Beat co-hosts Drs. Vaduganathan and Greene on their top picks from the late-breaking sessions at the upcoming American College of Cardiology meeting.

Nearly all of the doctors polled recommended the pneumococcal vaccine for patients with cardiovascular disease aged 65 years and older.

Investigators conducted the largest study on SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses.

Dr. Bailey highlights the innovative nature of the procedure and breaks down the process at his institution.

The resolution of excess central retinal thickness in response to anti-VEGF therapy and the treatment burden were additionally similar between the 2 groups.

Human milk oligosaccharides could help treat some of the gut disruptions patients with depression often have.

“The effects of coffee consumption on SUA levels and gout risk are controversial,” investigators explained. “There have hitherto been no reports based on its effects that consider pleiotropy.”

From the struggle of obtaining insurance approvals to addressing the nationwide shortage of rheumatologists, Dr. Baker Frost talks about her experience treating patients with autoimmune disease.

Fecal microbiota transplantation is known to cure up to 88% of patients with recurrent C difficile infections.

Bristol Myers Squibb has to wait 3 months for FDA decision on Reblozyl for treating non-transfusion-dependent β-thalassemia.

The therapy is indicated for conditions associated with hypogonadism in adult males.

In a population aged 70 years and older, a remote history of VT was associated with an increased risk of VT independent of other factors.

A new AAD study shows board-certified experts produce only one-fourth of the most popular TikTok posts on subjects in their field.

With the newest indication, the GLP-1 agonist is now available in 3 different doses for diabetic adults.

An assessment of long-term VOYAGER 1 and 2 trial data show the IL-23 biologic provides significant benefit toward skin clearance, regardless of baseline characteristics.

The VALIANT study featured a cross-sectional online survey that was used to recruit adult patients 18 years and older who were professionally diagnosed with vitiligo.

Data from the ADhere studies found that lebrikizumab was well tolerated in patients with atopic dermatitis.

“[Some] Patients may benefit from switching to a fully human biologic, such as IV-golimumab, to control disease activity/improve drug tolerance," investigators stated.